ProMIS Neurosciences, Inc.
NCM: PMNLive Quote
📈 ZcoreAI Score
Our AI model analyzes ProMIS Neurosciences, Inc.'s price action across multiple timeframes using regression channels and statistical scoring.
Get PMN Z-Score →About ProMIS Neurosciences, Inc.
Healthcare
Biotechnology
ProMIS Neurosciences, Inc. discovers and develops antibody therapies and therapeutic vaccines for neurodegenerative diseases and other misfolded protein diseases in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms to predict novel targets known as disease specific epitopes on the molecular surface of misfolded proteins. Its lead product candidates comprise of PMN310, a monoclonal antibody (mAb) for toxic oligomers for treating Alzheimer's Disease; PMN267 for treatment of amyotrophic lateral sclerosis; and PMN442, a mAb targeting toxic a-syn oligomers and seeding fibrils for treating multiple system atrophy. The company also develops PNM440, an alpha-synuclein vaccine for treating multiple synucleinopathies; and PMN311, an amyloid-beta vaccine for treatment of Alzheimer's. In addition, it is developing therapies for frontotemporal lobar degeneration, Huntington's disease, progressive supranuclear palsy, corticobasal degeneration, and schizophrenia. The company was formerly known as Amorfix Life Sciences Ltd. and changed its name to ProMIS Neurosciences, Inc. in July 2015. ProMIS Neurosciences, Inc. is headquartered in Toronto, Canada.
📊 Fundamental Analysis
ProMIS Neurosciences, Inc. demonstrates a profit margin of 0.0%, which is below the sector average, suggesting competitive pressure.
Return on Equity (ROE) is -521.6%, which indicates that capital utilization is currently under pressure.
At a current price of $12.60, PMN currently trades near the bottom of its 52-week range (19%), indicating potential value or weakness (Range: $6.27 - $39.75).
🏥 Financial Health
🔴
Profit Margin
Weak
🔴
Return on Equity
Weak
✅
Beta (Risk)
Low Volatility
Key Financials
Market Cap
$112.99M
Trailing P/E
--
Forward P/E
-20.66
Beta (5Y)
-0.15
52W High
$39.75
52W Low
$6.27
Avg Volume
181K
Day High
Day Low